MS

Mridul Saurav Nath

Active Director Director DIN 10895861
DIN 10895861 First appointment Jan 2025 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Mridul Saurav Nath

Data last updated:

Mridul Saurav Nath is a Director at Avenix Biotech Private Limited (since 2025). The company operates in Paper.

DIN 10895861
Primary Designation Director
Industry Paper
First Appointment 03 Jan 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Avenix Biotech Private Limited U21000AS2025PTC027456
Director03 Jan 20252025Active

Board colleagues of Mridul Saurav Nath

NameDINCompanyDesignation
Arun Dixit10895862Avenix Biotech Private LimitedDirector
Kasturima Bora10895860Avenix Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Avenix Biotech Private Limited
Premium access

Shareholding and investment profile for Mridul Saurav Nath

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mridul Saurav Nath

Mridul Saurav Nath currently holds 1 directorship: Avenix Biotech Private Limited (Director, since 03 Jan 2025).

Mridul Saurav Nath was first appointed on 03 Jan 2025 as Director at Avenix Biotech Private Limited.

The current boards of Mridul Saurav Nath's companies include Arun Dixit (Avenix Biotech Private Limited), Kasturima Bora (Avenix Biotech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available